Cardiovascular events in chronic dialysis patients: Emphasizing the importance of vascular disease prevention

International Urology and Nephrology

Volumn 42, Issue 4, 2010, Pages 999-1006

  Paraskevas, Kosmas I ^a   Kotsikoris, Ioannis ^a   Koupidis, Sotirios A ^b   Tzovaras, Alexandros A ^c   Mikhailidis, Dimitri P ^d  

^a RED CROSS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Agios Savvas Cancer Hospital   (Greece)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic kidney disease; Hemodialysis; Mortality; Peritoneal dialysis; Vascular disease prevention

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLSALICYLIC ACID; ATORVASTATIN; CALCIUM; CLOPIDOGREL; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHORUS; PLACEBO; ROSUVASTATIN;

ARTICLE; BLEEDING; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; DYSLIPIDEMIA; GLYCEMIC CONTROL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; MINERAL METABOLISM; MORTALITY; PATIENT ATTITUDE; PHOSPHATE METABOLISM; RISK ASSESSMENT; RISK REDUCTION; SMOKING CESSATION; VITAMIN BLOOD LEVEL;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; HEMOGLOBINS; HUMANS; METABOLIC DISEASES; RENAL DIALYSIS; RISK FACTORS;

EID: 78751648160     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-010-9795-7     Document Type: Article

References (73)

1. YK Kim SJ Shin S-H Ihm, et al. 2010 Association between N-terminal pro-brain natriuretic peptide and acute ischemic stroke in patients on chronic hemodialysis Int Urol Nephrol 10.1007/s11255-009-9689-8
2. D Banerjee G Contreras I Jaraba, et al. 2009 Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population Int Urol Nephrol 41 443 451 10.1007/s11255-008-9514-9 19117116
3. KB Meyer AS Levey 1998 Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the national kidney foundation task force on cardiovascular disease J Am Soc Nephrol 9 12 Suppl S31 S42 1:STN:280:DC%2BD3MzovF2ksw%3D%3D 11443766
4. CA Herzog JM Mangrum R Passman 2008 Sudden cardiac death and dialysis patients Semin Dial 21 300 307 10.1111/j.1525-139X.2008.00455.x 18627568
5. RN Foley PS Parfrey MJ Sarnak 1998 Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 12 Suppl S16 S23 1:STN:280:DC%2BD3MzovF2lug%3D%3D 11443763
6. D Oreopoulos E Thodis KI Paraskevas 2008 The promising future of long-term peritoneal dialysis Int Urol Nephrol 40 405 410 10.1007/s11255-008- 9370-7 18368504
7. AJ Collins RN Foley C Herzog, et al. 2009 United States renal data system 2008 annual data report Am J Kidney Dis 53 Suppl 1 S1 S374
8. N Dimkovic DG Oreopoulos 2008 Assisted peritoneal dialysis as a method of choice for elderly with end-stage renal disease Int Urol Nephrol 40 1143 1150 10.1007/s11255-008-9427-7 18649003
9. NG Kutner 2008 Promoting functioning and well-being in older CKD patients: review of recent evidence Int Urol Nephrol 40 1151 1158 10.1007/s11255-008-9469-x 18787971
10. K Kalantar-Zadeh KC Abbott AK Salahudeen RD Kilpatrick TB Horwich 2005 Survival advantages of obesity in dialysis patients Am J Clin Nutr 81 543 554 15755821
11. SF Leavey K McCullough E Hecking D Goodkin FK Port EW Young 2001 Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the dialysis outcomes and practice patterns study (DOPPS) Nephrol Dial Transplant 16 2386 2394 1:STN:280:DC%2BD3MnpsVGitQ%3D%3D 10.1093/ndt/16.12.2386 11733631
12. P Hirachan S Thijssen NW Levin P Kotanko 2008 Body composition and outcomes in chronic hemodialysis patients Contrib Nephrol 161 108 114 10.1159/000130422 18451665
13. BD Bradbury RB Fissell JM Albert, et al. 2007 Predictors of early mortality among incident US hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS) Clin J Am Soc Nephrol 2 89 99 10.2215/CJN.01170905 17699392
14. E Lacson Jr JM Lazarus 2007 The association between blood pressure and mortality in ESRD-not different from the general population? Semin Dial 20 510 517 10.1111/j.1525-139X.2007.00339.x 17991196
15. Z Li E Lacson Jr EG Lowrie, et al. 2006 The epidemiology of systolic blood pressure and death risk in hemodialysis patients Am J Kidney Dis 48 606 615 10.1053/j.ajkd.2006.07.005 16997057 (Pubitemid 44425376)
16. R Lacson 2008 Predicting hemodialysis mortality utilizing blood pressure trends AMIA Annu Symp Proc Nov 6 369 373
17. G Deferrari M Ravera V Berruti G Leoncini L Deferrari 2004 Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment J Am Soc Nephrol 15 Suppl 1 S6 S11 1:CAS:528:DC%2BD3sXps1Siur0%3D 10.1097/01.ASN.0000105881.71167.44 14684664
18. RJ Perry W Griffiths P Dextraze RJ Solomon WM Trebbin 1984 Elevated nicotine levels in patients undergoing hemodialysis. A role in cardiovascular mortality and morbidity? Am J Med 76 241 246 1:STN:280:DyaL2c7isFeruw%3D%3D 10.1016/0002-9343(84)90780-0 6695947 (Pubitemid 14157838)
19. G Biesenbach J Zazgornik 1996 Influence of smoking on the survival rate of diabetic patients requiring hemodialysis Diabetes Care 19 625 628 1:STN:280:DyaK28zkvVyitQ%3D%3D 10.2337/diacare.19.6.625 8725862
20. JM Soucie WM McClellan 1996 Early death in dialysis patients: risk factors and impact on incidence and mortality rates J Am Soc Nephrol 7 2169 2175 1:STN:280:DyaK2s%2Fntlahuw%3D%3D 8915977
21. RN Foley CA Herzog AJ Collins 2003 Smoking and cardiovascular outcomes in dialysis patients: the United States renal data system wave 2 study Kidney Int 63 1462 1467 10.1046/j.1523-1755.2003.00860.x 12631362 (Pubitemid 36350011)
22. M Koch R Trapp W Kulas B Grabensee 2004 Critical limb ischaemia as the main cause of death in patients with end-stage renal disease: a single centre study Nephrol Dial Transplant 19 2547 2552 10.1093/ndt/gfh404 15266035 (Pubitemid 39360102)
23. S Rajagopalan S Dellegrottaglie AL Furniss, et al. 2006 Peripheral arterial disease in patients with end-stage renal disease: observations from the dialysis outcomes and practice patterns study (DOPPS) Circulation 114 1914 1922 10.1161/CIRCULATIONAHA.105.607390 17060384 (Pubitemid 44665385)
24. KI Paraskevas 2008 Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering Int Urol Nephrol 40 165 170 1:CAS:528: DC%2BD1cXjsVGjt74%3D 10.1007/s11255-007-9307-6 18066677
25. K Tziomalos VG Athyros A Karagiannis DP Mikhailidis 2009 Dyslipidemia as a risk factor for ischemic stroke Curr Top Med Chem 9 1291 1297 1:CAS:528:DC%2BD1MXhs1WhurjO 10.2174/156802609789869628 19849661
26. KI Paraskevas V Stathopoulos DP Mikhailidis 2008 Pleiotropic effects of statins: implications for a wide range of diseases Curr Vasc Pharmacol 6 237 239 1:CAS:528:DC%2BD1cXhtFKms73K 10.2174/157016108785909724 18855711
27. H Soran P Durrington 2008 Rosuvastatin: efficacy, safety and clinical effectiveness Expert Opin Pharmacother 9 2145 2160 1:CAS:528: DC%2BD1cXpt1SmsL8%3D 10.1517/14656566.9.12.2145 18671469
28. KI Paraskevas N Bessias TP Perdikides DP Mikhailidis 2009 Statins and venous thromboembolism: a novel effect of statins? Curr Med Res Opin 25 1807 1809 1:CAS:528:DC%2BD1MXnsFKqsb4%3D 10.1185/03007990903052591 19505206
29. J Rysz WS Aronow RS Stolarek S Hannam DP Mikhailidis M Banach 2009 Nephroprotective and clinical potential of statins in dialyzed patients Expert Opin Ther Targets 13 541 550 1:CAS:528:DC%2BD1MXltVOmurs%3D 10.1517/ 14728220902882130 19368496
30. KI Paraskevas CD Liapis G Hamilton DP Mikhailidis 2008 Are statins an option in the management of abdominal aortic aneurysms? Vasc Endovascular Surg 42 128 134 10.1177/1538574407308205 18421030 (Pubitemid 351550928)
31. GF Strippoli SD Navaneethan DW Johnson, et al. 2008 Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 645 651 1:CAS:528:DC%2BD1cXltVKgsrw%3D 10.1136/bmj.39472.580984.AE 18299289 (Pubitemid 351481234)
32. SL Seliger NS Weiss DL Gillen, et al. 2002 HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients Kidney Int 61 297 304 1:CAS:528:DC%2BD38XlslGlsQ%3D%3D 10.1046/j.1523-1755.2002.00109.x 11786112 (Pubitemid 34075157)
33. NA Mason GR Bailie S Satayathum, et al. 2005 HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients Am J Kidney Dis 45 119 126 1:CAS:528:DC%2BD2MXhtVOrtrc%3D 10.1053/j.ajkd.2004.09. 025 15696451 (Pubitemid 40038052)
34. C Wanner V Krane W Marz, et al. 2005 Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 238 248 1:CAS:528:DC%2BD2MXmt1Kms7s%3D 10.1056/NEJMoa043545 16034009 (Pubitemid 41058323)
35. BC Fellström AG Jardine RE Schmieder AURORA Study Group, et al. 2009 Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 1395 1407 10.1056/NEJMoa0810177 19332456
36. Chung BH, Lim SW, Ahn KO et al. (2005) Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases. Nephrology (Carlton) 10 Suppl:S40-S43
37. YL Kim 2007 Can we overcome the predestined poor survival of diabetic patients? Perspectives from pre- and post-dialysis Perit Dial Int 27 Suppl 2 S171 S175 17556299
38. H Yki-Jarvinen 2004 Thiazolidinediones N Engl J Med 351 1106 1118 10.1056/NEJMra041001 15356308 (Pubitemid 39167514)
39. S Singh YK Loke CD Furberg 2007 Long-term risks of cardiovascular events with rosiglitazone: a meta-analysis JAMA 298 1189 1195 1:CAS:528: DC%2BD2sXhtVGmtL3K 10.1001/jama.298.10.1189 17848653 (Pubitemid 47403105)
40. FY Hsiao WF Huang YW Wen, et al. 2009 Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473, 000 patients using the National Health Insurance database in Taiwan Drug Saf 32 675 690 1:CAS:528:DC%2BD1MXhtFOku7rL 10.2165/00002018-200932080-00006 19591532
41. WG Herrington JB Levy 2008 Metformin: effective and safe in renal disease? Int Urol Nephrol 40 411 417 1:CAS:528:DC%2BD1cXmtlSrsrg%3D 10.1007/s11255-008-9371-6 18368503
42. JS Kaufman TZ O'Connor JH Zhang Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis, et al. 2003 Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis J Am Soc Nephrol 14 2313 2321 1:CAS:528:DC%2BD3sXmtl2ltbo%3D 10.1097/01.ASN. 0000081661.10246.33 12937308 (Pubitemid 37052378)
43. RM Holden GJ Harman M Wang D Holland AG Day 2008 Major bleeding in hemodialysis patients Clin J Am Soc Nephrol 3 105 110 10.2215/CJN.01810407 18003768
44. KE Chan JM Lazarus R Thadhani RM Hakim 2009 Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients J Am Soc Nephrol 20 872 881 1:CAS:528:DC%2BD1MXltFyjsrw%3D 10.1681/ASN.2008080824 19297555
45. S Hiremath RM Holden D Fergusson DL Zimmerman 2009 Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates Clin Am J Soc Nephrol 4 1347 1355 1:CAS:528:DC%2BD1MXhtV2qur3L 10.2215/CJN.00810209
46. C Zoccali G Tripepi F Mallamaci 2005 Predictors of cardiovascular death in ESRD Semin Nephrol 25 358 362 10.1016/j.semnephrol.2005.05.002 16298255 (Pubitemid 41655967)
47. J Portoles JM Lopez-Gomez P Aljama 2007 A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR study Nephrol Dial Transplant 22 500 507 10.1093/ndt/gfl558 17023492 (Pubitemid 46189895)
48. MA Pfeffer EA Burdmann CY Chen TREAT Investigators, et al. 2009 A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2019 2032 10.1056/NEJMoa0907845 19880844
49. AK Singh L Szcsech KL Tang CHOIR Investigators, et al. 2006 Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2085 2098 1:CAS:528:DC%2BD28Xht1Wqt7fN 10.1056/NEJMoa065485 17108343 (Pubitemid 44749317)
50. TB Drüeke F Locatelli N Clyne CREATE Investigators, et al. 2006 Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2071 2084 10.1056/NEJMoa062276 17108342 (Pubitemid 44749316)
51. KDOQI 2007 KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target Am J Kidney Dis 50 471 530 10.1053/j.ajkd.2007.06.008 (Pubitemid 47285453)
52. TV Patel AK Singh 2009 Role of vitamin D in chronic kidney disease Semin Nephrol 29 113 121 1:CAS:528:DC%2BD1MXlvVahtL8%3D 10.1016/j.semnephrol.2009.01. 004 19371802
53. ML Melamed JA Eustace L Plantiga, et al. 2006 Changes in serum calcium, phosphate and PTH and the risk of death in incident dialysis patients: a longitudinal study Kidney Int 70 351 357 1:CAS:528:DC%2BD28XmvFagsL8%3D 10.1038/sj.ki.5001542 16738536 (Pubitemid 44086585)
54. M Teng M Wolf E Lowrie, et al. 2003 Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N Engl J Med 349 446 456 1:CAS:528:DC%2BD3sXms1Ogsrg%3D 10.1056/NEJMoa022536 12890843 (Pubitemid 36910023)
55. CP Kovesdy S Ahmadzadeh JE Anderson, et al. 2008 Association of activated vitamin D treatment and mortality in chronic kidney disease Arch Intern Med 168 397 403 1:CAS:528:DC%2BD1cXjtlemsrw%3D 10.1001/archinternmed.2007.110 18299495 (Pubitemid 351350586)
56. AB Shoben KD Rudser IH de Boer, et al. 2008 Association of oral calcitriol with improved survival in nondialyzed CKD J Am Soc Nephrol 19 1613 1619 1:CAS:528:DC%2BD1cXhtVWltrrI 10.1681/ASN.2007111164 18463168
57. B Pecovnik-Balon E Jakopin S Bevc, et al. 2009 Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients Ther Apher Dial 13 268 272 1:CAS:528:DC%2BD1MXhtFGmt7rO 10.1111/j.1744-9987.2009.00722.x 19695057
58. M Teng M Wolf MN Ofsthun, et al. 2005 Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol 16 1115 1125 1:CAS:528:DC%2BD2MXjsVWqt70%3D 10.1681/ASN.2004070573 15728786 (Pubitemid 41710323)
59. M Wolf A Shah O Gutierrez, et al. 2007 Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 72 1004 1013 1:CAS:528:DC%2BD2sXhtFagtr%2FM 10.1038/sj.ki.5002451 17687259 (Pubitemid 47530570)
60. P Messa 2008 Impact of Ca/P disorders on risks and comorbidities Contrib Nephrol 161 215 221 10.1159/000130680 18451680
61. WG Goodman J Goldin BD Kuizon, et al. 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478 1483 1:STN:280:DC%2BD3c3ls1OjtA%3D%3D 10.1056/NEJM200005183422003 10816185 (Pubitemid 30318271)
62. J Blacher AP Guerin B Pannier, et al. 2001 Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 938 942 1:CAS:528:DC%2BD3MXotVGlsr4%3D 10.1161/hy1001.096358 11641313
63. AR Sehgal C Sullivan JB Leon, et al. 2008 Public health approach to addressing hyperphosphatemia among dialysis patients J Ren Nutr 18 256 261 10.1053/j.jrn.2007.12.002 18410881 (Pubitemid 351503905)
64. GA Block PS Klassen JM Lazarus, et al. 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208 2218 1:CAS:528:DC%2BD2cXlvVKmu7w%3D 10.1097/01.ASN.0000133041.27682.A2 15284307 (Pubitemid 39031360)
65. EW Young JM Albert S Satayathum, et al. 2005 Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study Kidney Int 67 1179 1187 1:CAS:528:DC%2BD2MXis1Gqs70%3D 10.1111/j.1523-1755. 2005.00185.x 15698460 (Pubitemid 41623345)
66. SK Ganesh AG Stack NW Levin, et al. 2001 Association of elevated serum PO(4), Ca x PO(4) product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2131 2138 1:CAS:528:DC%2BD3MXnsFWiurk%3D 11562412
67. M Morena N Terrier I Jaussent, et al. 2006 Plasma osteoprotegerin is associated with mortality in hemodialysis patients J Am Soc Nephrol 17 262 270 1:CAS:528:DC%2BD28XhtF2jsr0%3D 10.1681/ASN.2005030260 16280472
68. GM London AP Guerin SJ Marchais, et al. 2003 Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Nephrol Dial Transplant 18 1731 1740 10.1093/ndt/gfg414 12937218 (Pubitemid 37098542)
69. M Matsuoka K Iseki M Tamashiro, et al. 2004 Impact of high coronary arterial calcification score (CACS) on survival in patients on chronic hemodialysis Clin Exp Nephrol 8 54 58 10.1007/s10157-003-0260-0 15067517 (Pubitemid 38508656)
70. F Tentori MJ Blayney JM Albert, et al. 2008 Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS) Am J Kidney Dis 52 519 530 1:CAS:528:DC%2BD1cXhtFOrt7zF 10.1053/j.ajkd.2008.03.020 18514987
71. F Turgut M Kanbay MR Metin, et al. 2008 Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis Int Urol Nephrol 40 1075 1082 1:CAS:528:DC%2BD1cXhtlCjur%2FE 10.1007/s11255-008-9410-3 18568412
72. I Tzanakis K Virvidakis A Tsomi, et al. 2004 Intra-and extracellular magnesium levels and atheromatosis in haemodialysis patients Magnes Res 17 102 108 1:CAS:528:DC%2BD2cXnsFWru74%3D 15319142
73. M Kanbay D Goldsmith ME Uyar, et al. 2010 Magnesium in chronic kidney disease: challenges and opportunities Blood Purif 29 280 292 1:CAS:528:DC%2BC3cXktVyisbg%3D 10.1159/000276665 20090315